DE3781337D1 - 2-oxo-1-(((substituiertes sulfonyl)amino)-carbonyl)-azetidine. - Google Patents

2-oxo-1-(((substituiertes sulfonyl)amino)-carbonyl)-azetidine.

Info

Publication number
DE3781337D1
DE3781337D1 DE8787108993T DE3781337T DE3781337D1 DE 3781337 D1 DE3781337 D1 DE 3781337D1 DE 8787108993 T DE8787108993 T DE 8787108993T DE 3781337 T DE3781337 T DE 3781337T DE 3781337 D1 DE3781337 D1 DE 3781337D1
Authority
DE
Germany
Prior art keywords
azetidine
oxo
carbonyl
amino
substituted sulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787108993T
Other languages
English (en)
Other versions
DE3781337T2 (de
Inventor
Hermann Breuer
Jakob-Matthias Drossard
Peter Hans Ermann
Henner Straub
Uwe Dietmar Treuner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb GmbH
Original Assignee
Bristol Myers Squibb GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb GmbH filed Critical Bristol Myers Squibb GmbH
Application granted granted Critical
Publication of DE3781337D1 publication Critical patent/DE3781337D1/de
Publication of DE3781337T2 publication Critical patent/DE3781337T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
DE8787108993T 1986-06-23 1987-06-23 2-oxo-1-(((substituiertes sulfonyl)amino)-carbonyl)-azetidine. Expired - Fee Related DE3781337T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/877,599 US4801705A (en) 1986-06-23 1986-06-23 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines

Publications (2)

Publication Number Publication Date
DE3781337D1 true DE3781337D1 (de) 1992-10-01
DE3781337T2 DE3781337T2 (de) 1992-12-17

Family

ID=25370302

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787108993T Expired - Fee Related DE3781337T2 (de) 1986-06-23 1987-06-23 2-oxo-1-(((substituiertes sulfonyl)amino)-carbonyl)-azetidine.

Country Status (18)

Country Link
US (1) US4801705A (de)
EP (1) EP0251143B1 (de)
JP (1) JPS635075A (de)
KR (1) KR900001007B1 (de)
AT (1) ATE79879T1 (de)
AU (1) AU603102B2 (de)
CA (1) CA1309097C (de)
DE (1) DE3781337T2 (de)
DK (1) DK317187A (de)
ES (1) ES2051711T3 (de)
FI (1) FI91865C (de)
GR (1) GR3006329T3 (de)
HU (1) HU198712B (de)
IE (1) IE59970B1 (de)
IL (1) IL82832A (de)
NZ (1) NZ220395A (de)
PH (1) PH24043A (de)
ZA (1) ZA873710B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG18314A (en) * 1985-09-26 1993-02-28 Squibb & Sons Inc Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US4777252A (en) * 1987-08-13 1988-10-11 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4980465A (en) * 1987-12-21 1990-12-25 E. R. Squibb & Sons, Inc. Process for making 2-oxo-1-[[(substituted sulfonyl)-amino]carbonyl)] azetidines and intermediates used therein
US4889930A (en) * 1987-12-21 1989-12-26 E. R. Squibb & Sons, Inc. Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein
US4871841A (en) * 1987-12-23 1989-10-03 E. R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
ZA892859B (en) * 1988-04-22 1989-12-27 Advanced Polymer Systems Inc Porous particles in preparations involving immiscible phases
EP0344707A3 (de) * 1988-06-02 1990-04-18 E.R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituiertes sulfony)-amino]carbonyl]-Azetidinderivate
FR2918062B1 (fr) * 2007-06-29 2010-04-23 Rhodia Recherches & Tech Procede de preparation de composes hydrazo-silanes mettant en oeuvre un precurseur hydrazocarboxylate alcoxyle
JP7013375B2 (ja) * 2015-09-04 2022-01-31 シンプン・ファーマシューティカル・カンパニー・リミテッド 血小板凝集阻害効果を有する化合物及びその塩、並びにそれを含む血栓性疾患予防又は治療用組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199981A (en) * 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines
US4587047A (en) * 1981-04-09 1986-05-06 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
CA1272726C (en) * 1982-01-04 1990-08-14 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines
US4670553A (en) * 1982-01-04 1987-06-02 E. R. Squibb & Sons, Inc. 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl)azetidines
US4743685A (en) * 1985-09-26 1988-05-10 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines

Also Published As

Publication number Publication date
NZ220395A (en) 1990-05-28
IL82832A (en) 1991-04-15
HUT44537A (en) 1988-03-28
JPS635075A (ja) 1988-01-11
AU7348987A (en) 1987-12-24
FI872784A (fi) 1987-12-24
ATE79879T1 (de) 1992-09-15
IL82832A0 (en) 1987-12-20
EP0251143A1 (de) 1988-01-07
GR3006329T3 (de) 1993-06-21
HU198712B (en) 1989-11-28
DK317187D0 (da) 1987-06-22
US4801705A (en) 1989-01-31
ZA873710B (en) 1987-11-18
ES2051711T3 (es) 1994-07-01
KR900001007B1 (ko) 1990-02-24
AU603102B2 (en) 1990-11-08
FI91865C (fi) 1994-08-25
IE871651L (en) 1987-12-23
PH24043A (en) 1990-03-05
DK317187A (da) 1987-12-24
EP0251143B1 (de) 1992-08-26
DE3781337T2 (de) 1992-12-17
CA1309097C (en) 1992-10-20
IE59970B1 (en) 1994-05-04
KR880000423A (ko) 1988-03-25
FI872784A0 (fi) 1987-06-23
FI91865B (fi) 1994-05-13

Similar Documents

Publication Publication Date Title
SE8604089L (sv) 2-oxo-1-//(substituerad sulfonyl)amino/karbonyl/-azetidiner
LV11459A (lv) Aizvietoti azetidinoni ka pretiekaisuma lidzekli
DE3781337D1 (de) 2-oxo-1-(((substituiertes sulfonyl)amino)-carbonyl)-azetidine.
ATE22439T1 (de) 2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine.
AU7927487A (en) Stabilized drug compositions
AU597632B2 (en) 2-oxo-1-(substituted phosphorous) azetidines
JPS6426577A (en) 2-oxo-1-(((substituted sulfonyl)amino)carbonyl) azetidines
EP0344707A3 (de) 2-Oxo-1-[[(substituiertes sulfony)-amino]carbonyl]-Azetidinderivate
EP0321928A3 (de) 2-Oxo-1-[[(substituiertes sulphonyl)amino]carbonyl]azetidine
ES2017640B3 (es) Derivado de triazina, su preparacion y empleo.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee